Home Tags Depression
Depression among Gen Z is skyrocketing — a troubling mental-health trend that could affect the rest of their lives
More young people are having depressive episodes, and it could spell trouble for years to come. Psychologists say there's more we could be doing.
Unlike the depression drugs available for decades, neither of the two new drugs is a pill. One is a nasal spray; the latest is an injection made by Sage.
The suicide death of a 23-year-old Olympic cyclist highlights a disturbing trend. Her former coach says we could be doing more.
People under 25 are dealing with alarming rates of depression, mental distress, and suicidal thoughts. Less sleep and more screen time may not help.
A new study on rats found that small doses of the psychedelic drug DMT could potentially help with anxiety and depression.
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential
A drug inspired by ketamine just became the first new type of depression drug in 35 years. The FDA approved the nasal spray made by Johnson & Johnson.
Too much loneliness can raise your risk of depression and heart disease, help Alzheimer's disease progress, and lower your ability to learn.
Half of children with PTSD had self-harmed, and one in five had attempted suicide, but just one in five had seen a mental health professional in the past year.
Depression affects as many as 1 in 7 new moms, but health experts just recommended an effective treatment that could prevent it
Counseling could be an effective way to prevent perinatal depression, according to a new recommendation from the US Preventive Services Task Force.
Recent research suggests the main psychoactive component in magic mushrooms, psilocybin, could be an alternative treatment for depression.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.